SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-320085
Filing Date
2020-12-17
Accepted
2020-12-17 16:26:58
Documents
7
Period of Report
2020-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61981d8k.htm 8-K 23241
2 EX-1.1 d61981dex11.htm EX-1.1 177373
3 EX-5.1 d61981dex51.htm EX-5.1 13062
4 EX-99.1 d61981dex991.htm EX-99.1 9193
5 EX-99.2 d61981dex992.htm EX-99.2 9260
6 GRAPHIC g61981g42g20.jpg GRAPHIC 3979
7 GRAPHIC g61981g95e69.jpg GRAPHIC 52435
  Complete submission text file 0001193125-20-320085.txt   311249
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 201396419
SIC: 2834 Pharmaceutical Preparations